Home Cart Sign in  
Chemical Structure| 2034-69-7 Chemical Structure| 2034-69-7

Structure of Daphnoretin
CAS No.: 2034-69-7

Chemical Structure| 2034-69-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Daphnoretin (Dephnoretin) is extracted from Wikstroemia indica and exhibits antiviral activity. Daphnoretin acts similar to PMA by directly activating protein kinase C, thereby activating NADPH oxidase.

Synonyms: Dephnoretin; Thymelol; Daphnoretin, NSC 291852, NSC291852, NSC-291852, BRN 1299325, BRN1299325, BRN-1299325

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Daphnoretin

CAS No. :2034-69-7
Formula : C19H12O7
M.W : 352.29
SMILES Code : O=C1C(OC2=CC=C(C(O3)=C2)C=CC3=O)=CC4=CC(OC)=C(O)C=C4O1
Synonyms :
Dephnoretin; Thymelol; Daphnoretin, NSC 291852, NSC291852, NSC-291852, BRN 1299325, BRN1299325, BRN-1299325
MDL No. :MFCD01082318

Safety of Daphnoretin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Daphnoretin

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEB cells 0, 10, 20, 40, 80, 100 μM 24 and 48 h To evaluate the effect of Daphnoretin on normal brain glial cells. Results showed that Daphnoretin had low toxicity on HEB cells. J Cancer. 2024 Sep 9;15(17):5810-5827.
U251 cells 0, 10, 20, 40, 80, 100 μM 24 and 48 h To evaluate the inhibitory effect of Daphnoretin on GBM cell proliferation. Results showed that Daphnoretin significantly inhibited GBM cell proliferation in a concentration-dependent manner. J Cancer. 2024 Sep 9;15(17):5810-5827.
U87 cells 0, 10, 20, 40, 80, 100 μM 24 and 48 h To evaluate the inhibitory effect of Daphnoretin on GBM cell proliferation. Results showed that Daphnoretin significantly inhibited GBM cell proliferation in a concentration-dependent manner. J Cancer. 2024 Sep 9;15(17):5810-5827.
human osteosarcoma (HOS) cells 1-4 μM 48 h Flow cytometric analysis showed Daphnoretin arrested the cell cycle in the G2/M phase in a concentration-dependent manner. Molecules. 2012 Jan 9;17(1):598-612.
human osteosarcoma (HOS) cells 1-4 μM 48 h Apoptosis was detected using Annexin V-FITC/PI apoptosis detection kit, showing Daphnoretin induced apoptosis in a concentration-dependent manner. Molecules. 2012 Jan 9;17(1):598-612.
human osteosarcoma (HOS) cells 3.89 μM 72 h To evaluate the antiproliferative activity of Daphnoretin on HOS cells, showing significant inhibitory effects. Molecules. 2012 Jan 9;17(1):598-612.
HEL cells 0.25 µM and 1.00 µM 24, 48, and 72 h Daphnoretin inhibited the growth of HEL cells in a dose- and time-dependent manner. Cells. 2022 Oct 16;11(20):3252.
K562 cells 0.25 µM and 1.00 µM 24, 48, and 72 h Daphnoretin inhibited the growth of K562 cells in a dose- and time-dependent manner. Cells. 2022 Oct 16;11(20):3252.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice GBM xenograft model Subcutaneous injection 20 mg/kg,40 mg/kg Daily administration for 14 days To evaluate the inhibitory effect of Daphnoretin on GBM tumor growth in vivo. Results showed that Daphnoretin significantly inhibited tumor growth with no significant toxicity. J Cancer. 2024 Sep 9;15(17):5810-5827.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.84mL

0.57mL

0.28mL

14.19mL

2.84mL

1.42mL

28.39mL

5.68mL

2.84mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories